Dammen-Brower, K. Epler, P., Zhu, S., Bernstein, Z.J., Stabach, P.R., Braddock, D.T., Spangler, J.B. & Yarema, K.J. (2022) Strategies for glycoengineering therapeutic proteins. Frontiers in Chemistry, 10, article 863118 (doi: 10.3389/fchem.2022.863118)
Agatemor, C., Buettner, M.J., Ariss, R., Muthiah, K., Saeui, C.T., & Yarema, K.J. (2019) Exploiting metabolic glycoengineering to advance healthcare. Nature Reviews Chemistry, 3, 605-620 (doi: 10.1038/s41570-019-0126-y) Pubmed
Buettner, M.J., Shah, S.R., Saeui, C.T., Ariss, R., & Yarema, K.J. (2018) Improving immunotherapy through glycodesign. Frontiers in Immunology, 9, article 2485 (doi: 10.3389/fimmu.2018.02485) Pubmed
Badr, H.A., AlSadek, D.M., El-Houseini, M.E., Saeui, C.T., Mathew, M.P., Yarema, K.J. & Ahmed, H. (2017) Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example. Biomaterials, 116, 158-173 (doi: 10.1016/j.biomaterials.2016.11.044) Pubmed
Saeui, C.T., Mathew, M.P., Liu, L., Urias, E., & Yarema K.J. (2015) Cell surface and membrane engineering: Emerging technologies and applications. Journal of Functional Biomaterials, 6, 454-485, (doi: 10.3390/jfb6020454) Pubmed
Saeui, C.T., Urias, E., Liu, L., Mathew, M.P., & Yarema K.J. (2015) Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications. Glycoconjugate Journal, 32, 425-441. (doi: 10.1007/s10719-015-9583-9) Pubmed
Almaraz, R.T., Mathew, M.P., Tan, E., & Yarema, K.J. (2012) Metabolic oligosaccharide engineering: Implications for selectin-mediated adhesion and leukocyte extravasation. Annals of Biomedical Engineering, 40, 806-815 (doi: 10.1007/s10439-011-0450-y) Pubmed
Du, J., & Yarema, K.J. (2010) Carbohydrate engineered cells for regenerative medicine. Advanced Drug Delivery Reviews, 62, 271-282 (doi: 10.1016/j.addr.2010.01.003) Pubmed
Wang, Z., Du, J., Che, P.-L., Meledeo, M.A., & Yarema, K.J. (2009) Hexosamine analogs: From metabolic glycoengineering to drug discovery. Current Opinion in Chemical Biology,13, 565-572 (doi: 10.1016/j.cbpa.2009.08.001) Pubmed
Du, J., Meledeo, M.A., Wang, Z., Khanna, H.S., & Yarema, K.J. (2009) Metabolic glycoengineering: Sialic acid and beyond. Glycobiology 19, 1382-1401 (doi: 10.1093/glycob/cwp115) Pubmed
Campbell, C.T. Sampathkumar, S.-G., & Yarema, K.J. (2007)Metabolic oligosaccharide engineering: perspectives, applications, and future directions. Molecular BioSystems, 3, 187-194 (doi: 10.1039/b614939c) Pubmed
Sampathkumar, S.-G., Campbell, C.T., Weier, C., & Yarema, K.J. (2006) Short-chain fatty acid-hexosamine cancer prodrugs: The sugar matters! Drugs of the Future, 31,1099-1116 (doi: 10.1358/dof.2006.031.12.1049173)
Sampathkumar, S.-G., Li, A., & Yarema, K.J. (2006)Sialic acid and the central nervous system: Perspectives on biological functions, detection and imaging methods, and manipulation. Current Drug Targets – CNS Disorders and Neurological Disorders,5, 425-440 (doi: 10.2174/187152706777950729) Pubmed
Campbell C.T. & Yarema, K.J. (2005) Large-scale approaches for glycobiology. Genome Biology, 6, 236-244 (doi: 10.1186/gb-2005-6-11-236) Pubmed
Yarema, K.J. & Sun, Z. (2005) A Photochemical snapshot of CD22 binding. Nature Chemical Biology, 1, 69-70 (doi: 10.1038/nchembio0705-69) Pubmed
Sampathkumar, S.-G. & Yarema, K.J. (2005). Targeting cancer cells with dendrimers. Chemistry & Biology, 12, 5-6 (doi: 10.1016/j.chembiol.2004.12.007) Pubmed
Murrell, M.P., Yarema, K.J., & Levchenko, A., (2004) The systems biology of glycosylation. ChemBioChem, 5, 1334-1347 (doi: 10.1002/cbic.200400143)
Yarema, K.J. (2001) New directions in carbohydrate engineering: A metabolic substrate-based approach to modify the cell surface display of sialic acids. Biotechniques, 31, 384-393 (doi: 10.2144/01312rv02) Pubmed
Yarema, K.J. & Bertozzi, C.R. (2001) Characterizing glycosylation pathways. Genome Biology, 2, REVIEWS0004-0010 (doi: 10.1186/gb-2001-2-5-reviews0004) Pubmed
Jacobs, C.L., Yarema, K.J., Mahal, L.K., Nauman, D.A., Charters, N., & Bertozzi, C.R. (2000) Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis. Methods in Enzymology,327, 260-275 (doi: 10.1016/s0076-6879(00)27282-0) Pubmed
Yarema, K.J. & Bertozzi, C.R. (1998) Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Current Opinion in Chemical Biology, 2, 49-61 (doi: 10.1016/s1367-5931(98)80035-5) Pubmed
Yarema, K.J. (1995) Comparative toxicities and mutagenicities of platinum anticancer drugs. Drug Information Journal, 29, 1633S-1644S (doi: 10.1177/00928615950290S110)
Yarema, K.J., & Essigmann, J.M. (1995) Evaluation of the genetic effects of defined DNA lesions formed by DNA damaging agents. Methods: A Companion to Methods in Enzymology, 7, 133-146